new version V2017

weight-loss drugs

Orlistat      

TrialStudied treatmentControl treatmentpatientsROBResultNCT

cardiovascular prevention

rimonabant
RIO europe 20mg, 2005rimonabant 20mgplaceboSuggesting
Rio-lipid 20 mg, 2005rimonabant 20mgplaceboSuggesting
RIO europe 5mg, 2005rimonabant 5mgplacebo Exploratory -
RIO europe (20 vs 5 mg), 2005rimonabant 20mgrimonabant 5mg -
RIO-North America 20 mg, 2006rimonabant 20mgplaceboSuggestingNCT00029861
CRESCENDO, 2010rimonabantplacebo Low risk of bias Negative NCT00263042
AUDITOR ongoing rimonabantplacebo -